As half of the battle towards coronavirus, vaccine research proceed with out slowing down all around the world.
The CEO of BioNTech, which developed the coronavirus vaccine with the US pharmaceutical firm Pfizer, Prof. Dr. Uğur Şahin made statements to the German press.
Making statements in regards to the results of the trials for youngsters, Şahin said that the info analysis course of took 4 to six weeks.
“FIRST RESULTS CAN BE TAKEN IN JULY AND SEPTEMBER”
prof. Dr. Uğur Şahin used the next statements:
“The primary results can be obtained for youngsters aged 5-12 in July and for youthful youngsters in September. If every part goes properly, we will be capable of apply for vaccination approval for all youngsters in the related age group in totally different international locations instantly after evaluating the info.”
FINAL STAGE BEFORE APPLICATION
He said that for youngsters aged 12 and over, they’re in the final stage earlier than making use of to the European Medicines Company.
“100% EFFECTIVE BETWEEN 12-15 PERCENT”
The Pfizer-BioNTech vaccine, administered as two doses, was permitted for use in folks aged 16 years and older.
In March, it was said that the vaccine produced by Pfizer in partnership with BioNTech is one hundred pc efficient in youngsters aged 12-15.
#Test #results #BioNTech #vaccines #babies #September
Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.
https://m.ensonhaber.com/dunya/bebekler-icin-biontech-asilarinin-test-sonuclari-eylulde-gelecek
